rs193074572

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000158.4(GBE1):​c.2017G>A​(p.Ala673Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00781 in 1,609,962 control chromosomes in the GnomAD database, including 64 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0051 ( 6 hom., cov: 32)
Exomes 𝑓: 0.0081 ( 58 hom. )

Consequence

GBE1
NM_000158.4 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: -1.20

Publications

12 publications found
Variant links:
Genes affected
GBE1 (HGNC:4180): (1,4-alpha-glucan branching enzyme 1) The protein encoded by this gene is a glycogen branching enzyme that catalyzes the transfer of alpha-1,4-linked glucosyl units from the outer end of a glycogen chain to an alpha-1,6 position on the same or a neighboring glycogen chain. Branching of the chains is essential to increase the solubility of the glycogen molecule and, consequently, in reducing the osmotic pressure within cells. Highest level of this enzyme are found in liver and muscle. Mutations in this gene are associated with glycogen storage disease IV (also known as Andersen's disease). [provided by RefSeq, Jul 2008]
GBE1 Gene-Disease associations (from GenCC):
  • glycogen storage disease due to glycogen branching enzyme deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Laboratory for Molecular Medicine, G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), ClinGen
  • adult polyglucosan body disease
    Inheritance: AR Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0044651926).
BP6
Variant 3-81499145-C-T is Benign according to our data. Variant chr3-81499145-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 235560.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00514 (782/152188) while in subpopulation NFE AF = 0.00836 (568/67980). AF 95% confidence interval is 0.00779. There are 6 homozygotes in GnomAd4. There are 359 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 6 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000158.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GBE1
NM_000158.4
MANE Select
c.2017G>Ap.Ala673Thr
missense
Exon 15 of 16NP_000149.4Q04446

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GBE1
ENST00000429644.7
TSL:1 MANE Select
c.2017G>Ap.Ala673Thr
missense
Exon 15 of 16ENSP00000410833.2Q04446
GBE1
ENST00000895874.1
c.2011G>Ap.Ala671Thr
missense
Exon 15 of 16ENSP00000565933.1
GBE1
ENST00000942742.1
c.2011G>Ap.Ala671Thr
missense
Exon 15 of 16ENSP00000612801.1

Frequencies

GnomAD3 genomes
AF:
0.00514
AC:
782
AN:
152070
Hom.:
6
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00130
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00655
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00249
Gnomad FIN
AF:
0.00274
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00835
Gnomad OTH
AF:
0.00526
GnomAD2 exomes
AF:
0.00502
AC:
1235
AN:
246198
AF XY:
0.00521
show subpopulations
Gnomad AFR exome
AF:
0.00183
Gnomad AMR exome
AF:
0.00252
Gnomad ASJ exome
AF:
0.00140
Gnomad EAS exome
AF:
0.0000563
Gnomad FIN exome
AF:
0.00285
Gnomad NFE exome
AF:
0.00843
Gnomad OTH exome
AF:
0.00486
GnomAD4 exome
AF:
0.00809
AC:
11799
AN:
1457774
Hom.:
58
Cov.:
29
AF XY:
0.00798
AC XY:
5790
AN XY:
725116
show subpopulations
African (AFR)
AF:
0.00108
AC:
36
AN:
33402
American (AMR)
AF:
0.00272
AC:
121
AN:
44462
Ashkenazi Jewish (ASJ)
AF:
0.00138
AC:
36
AN:
26058
East Asian (EAS)
AF:
0.0000253
AC:
1
AN:
39596
South Asian (SAS)
AF:
0.00288
AC:
247
AN:
85696
European-Finnish (FIN)
AF:
0.00328
AC:
175
AN:
53310
Middle Eastern (MID)
AF:
0.000520
AC:
3
AN:
5764
European-Non Finnish (NFE)
AF:
0.00975
AC:
10813
AN:
1109236
Other (OTH)
AF:
0.00609
AC:
367
AN:
60250
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.456
Heterozygous variant carriers
0
499
998
1497
1996
2495
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
428
856
1284
1712
2140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00514
AC:
782
AN:
152188
Hom.:
6
Cov.:
32
AF XY:
0.00482
AC XY:
359
AN XY:
74412
show subpopulations
African (AFR)
AF:
0.00130
AC:
54
AN:
41538
American (AMR)
AF:
0.00655
AC:
100
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.00173
AC:
6
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5190
South Asian (SAS)
AF:
0.00249
AC:
12
AN:
4818
European-Finnish (FIN)
AF:
0.00274
AC:
29
AN:
10596
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00836
AC:
568
AN:
67980
Other (OTH)
AF:
0.00520
AC:
11
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
43
86
129
172
215
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00693
Hom.:
6
Bravo
AF:
0.00539
TwinsUK
AF:
0.00917
AC:
34
ALSPAC
AF:
0.00934
AC:
36
ESP6500AA
AF:
0.00164
AC:
6
ESP6500EA
AF:
0.00660
AC:
54
ExAC
AF:
0.00496
AC:
599
Asia WGS
AF:
0.00115
AC:
4
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
7
not provided (7)
-
-
2
not specified (2)
-
-
1
Adult polyglucosan body disease (1)
-
-
1
Glycogen storage disease, type IV (1)
-
-
1
Glycogen storage disease, type IV;C1849722:Adult polyglucosan body disease (1)
-
-
1
Glycogen storage disease, type IV;C1856301:Glycogen storage disease IV, classic hepatic (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.073
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
15
DANN
Benign
0.96
DEOGEN2
Benign
0.27
T
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.038
N
LIST_S2
Benign
0.65
T
M_CAP
Benign
0.021
T
MetaRNN
Benign
0.0045
T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
0.72
N
PhyloP100
-1.2
PrimateAI
Benign
0.33
T
PROVEAN
Benign
0.31
N
REVEL
Benign
0.17
Sift
Benign
0.14
T
Sift4G
Benign
0.43
T
Polyphen
0.040
B
Vest4
0.13
MVP
0.58
MPC
0.030
ClinPred
0.015
T
GERP RS
-6.4
Varity_R
0.31
gMVP
0.26
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs193074572; hg19: chr3-81548296; COSMIC: COSV107525264; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.